1. Home
  2. GATX vs BLLN Comparison

GATX vs BLLN Comparison

Compare GATX & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GATX Corporation

GATX

GATX Corporation

HOLD

Current Price

$178.96

Market Cap

6.2B

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$132.63

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GATX
BLLN
Founded
1898
2016
Country
United States
United States
Employees
N/A
713
Industry
Transportation Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.0B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
GATX
BLLN
Price
$178.96
$132.63
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$215.50
$126.71
AVG Volume (30 Days)
210.6K
706.5K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
1.36%
N/A
EPS Growth
17.22
N/A
EPS
2.35
N/A
Revenue
$1,740,400,000.00
N/A
Revenue This Year
$42.21
$46.29
Revenue Next Year
$3.35
$30.14
P/E Ratio
$75.80
N/A
Revenue Growth
9.77
N/A
52 Week Low
$148.20
$61.96
52 Week High
$205.56
$138.70

Technical Indicators

Market Signals
Indicator
GATX
BLLN
Relative Strength Index (RSI) 52.72 64.49
Support Level $166.38 $79.07
Resistance Level $183.47 $138.70
Average True Range (ATR) 4.86 7.07
MACD 0.24 -0.17
Stochastic Oscillator 73.90 92.55

Price Performance

Historical Comparison
GATX
BLLN

About GATX GATX Corporation

GATX Corp leases transportation assets, including railcars, aircraft spare engines, and tank containers, to customers in North America, Europe, and India. The company's reportable business segments are: Rail North America, Rail International, Engine Leasing, and Other. The majority of its revenue is generated from the Rail North America segment, which is composed of the company's operations in the United States, Canada, and Mexico. This segment mainly provides railcars pursuant to full-service leases under which it maintains the railcars, pays ad valorem taxes and insurance, and provides other ancillary services.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: